Article Information
History
- August 8, 2024.
Article Versions
- Version 1 (February 1, 2024 - 14:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andrea Shin1,#,*,
- Yue Xing2,
- Mohammed Rayyan Waseem3,
- Robert Siwiec3,
- Toyia James-Stevenson3,
- Nicholas Rogers3,
- Matthew Bohm3,
- John Wo3,
- Carolyn Lockett3,
- Anita Gupta3,
- Jhalka Kadariya3,
- Evelyn Toh4,
- Rachel Anderson3,
- Huiping Xu5 and
- Xiang Gao2,#,*
- 1Vatche and Tamar Manoukian Division of Digestive Diseases at the University of California Los Angeles, Los Angeles, CA
- 2Department of Medicine at Stritch School of Medicine, Loyola University Chicago, Chicago, IL
- 3Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN
- 4Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN
- 5Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana
- ↵#Correspondence: Andrea S. Shin, M.D., M.Sc.; G. Oppenheimer Center for Neurobiology of Stress and Resilience; David Geffen School of Medicine at UCLA; 10833 Le Conte Avenue, CHS 42-210; Los Angeles, CA 90095-7378; Tel: (310) 206-0192; Fax: (310) 825-1919 Xiang Gao, PhD.; Department of Medicine; Stritch School of Medicine at Loyola University Chicago; 2160 S. Frist Avenue; Maywood, IL 60153; Tel: (708) 327-9021 asshin{at}mednet.ucla.edu
Posted August 08, 2024.
Microbiota-Short Chain Fatty Acid Relationships Underlie Clinical Heterogeneity and Identify Key Microbial Targets in Irritable Bowel Syndrome (IBS)
